Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Gastric Cancer

  Free Subscription


27.10.2025

2 Cancer Res
1 Eur J Surg Oncol
2 Gastroenterology
1 Gut
3 Int J Cancer
3 N Engl J Med
1 Surgery


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Cancer Res

  1. WANG Q, Zhong L, Wang X, Zhang Z, et al
    RORgamma Hijacks HIF-1alpha to Promote Peritoneal Metastasis of Gastric Cancer.
    Cancer Res. 2025 Oct 23. doi: 10.1158/0008-5472.CAN-25-1690.
    PubMed         Abstract available

  2. XU Y, Ye Z, Lin Z, Qian X, et al
    Disrupting Paraspeckle Stability by Targeting WTX-NONO Phase Separation Enhances Chemotherapy Efficacy in Gastric Cancer.
    Cancer Res. 2025 Oct 20. doi: 10.1158/0008-5472.CAN-25-1747.
    PubMed         Abstract available


    Eur J Surg Oncol

  3. REN M, Chu Y, Han R, Chen Y, et al
    Risk factors for lymph node metastasis and survival: Toward better endoscopic selection in ulcerative versus nonulcerative early gastric cancer.
    Eur J Surg Oncol. 2025;51:110497.
    PubMed         Abstract available


    Gastroenterology

  4. SU Y, Xing H, Zhang LY
    Comments on "Electroacupuncture Reduces Duration of Postoperative Ileus After Laparoscopic Gastrectomy for Gastric Cancer".
    Gastroenterology. 2025 Oct 23:S0016-5085(25)05967.
    PubMed        

  5. HUANG C, Wang X, Zhang X
    Interpreting a Study on the Use of Electroacupuncture to Reduce Duration of Postoperative Ileus After Laparoscopic Gastrectomy for Gastric Cancer.
    Gastroenterology. 2025 Oct 23:S0016-5085(25)05971.
    PubMed        


    Gut

  6. WANG K, Xie CJ, Ding Z, Shan T, et al
    PDE5A(+) cancer-associated fibroblasts enhance immune suppression in gastric cancer.
    Gut. 2025 Oct 20:gutjnl-2025-335794. doi: 10.1136/gutjnl-2025-335794.
    PubMed         Abstract available


    Int J Cancer

  7. MATSUBARA Y, Masuishi T, Hosoda W, Hirano H, et al
    Ramucirumab-containing chemotherapy for patients with gastrointestinal neuroendocrine carcinoma refractory/intolerant to platinum-based chemotherapy: A multicenter observational retrospective study (WJOG13420G).
    Int J Cancer. 2025;157:2577-2588.
    PubMed         Abstract available

  8. KRAEMER M, Wirsik NM, Alakus H, Schloesser HA, et al
    Adjuvant FLOT provides survival benefit for oesophagogastric junction and gastric adenocarcinoma patients with low tumour regression after neoadjuvant chemotherapy.
    Int J Cancer. 2025;157:2558-2568.
    PubMed         Abstract available

  9. CASTILLO-ITURRA J, Llach J, Luzko I, Aguilera L, et al
    Performance of upper gastrointestinal endoscopy in CDH1 germline pathogenic variant carriers: A multicenter study.
    Int J Cancer. 2025;157:2550-2557.
    PubMed         Abstract available


    N Engl J Med

  10. JANJIGIAN YY, Heilbron E, Tabernero J
    Perioperative Durvalumab in Gastric Cancer. Reply.
    N Engl J Med. 2025;393:1653-1654.
    PubMed        

  11. HOEPPNER J
    Perioperative Durvalumab in Gastric Cancer.
    N Engl J Med. 2025;393:1653.
    PubMed        

  12. LI S
    Perioperative Durvalumab in Gastric Cancer.
    N Engl J Med. 2025;393:1652-1653.
    PubMed        


    Surgery

  13. DUDZIC W, Kimilu N, Kapala A, Swierblewski M, et al
    Preoperative prognostic nutritional index and albumin levels are associated with cancer staging in patients undergoing gastrectomy.
    Surgery. 2025;187:109659.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.